Many seriously ill people die waiting for the FDA to approve drugs that regulators in other advanced countries have already ...

Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days ...

Instead, they’re left wondering how their pets ended up hurt or dead, after getting a shot that was supposed to give them new ...

Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

EPA proposed to require a label on existing plastic shipping pallets that contain decaBDE to provide notice that personal protective equipment (PPE) is required during the recycling of the pallets.

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.

Findings showed no increased risk of pregnancy, birth, or neonatal/infant outcomes with Flublok compared with standard-dose flu vaccine and estimated pregnancy outcomes for the general population.

The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...

The EMA has granted approval for Sanofi/Regeneron’s Dupixent (dupilumab) to treat EoE in children as young as one.

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...